<?xml version="1.0" ?>
<informationTable xsi:schemaLocation="http://www.sec.gov/edgar/document/thirteenf/informationtable eis_13FDocument.xsd" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:n1="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <infoTable>
    <nameOfIssuer>AGILE THERAPEUTICS INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00847L100</cusip>
    <value>15883</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2275455</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2275455</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CEMPRA INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>15130J109</cusip>
    <value>28872</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1193060</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1193060</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CHIMERIX INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>16934W106</cusip>
    <value>2620</value>
    <shrsOrPrnAmt>
      <sshPrnamt>472943</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>472943</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ESPERION THERAPEUTICS INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>29664W105</cusip>
    <value>22674</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1637125</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1637125</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>INTERSECT ENT INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>46071F103</cusip>
    <value>3936</value>
    <shrsOrPrnAmt>
      <sshPrnamt>248498</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>248498</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>LOMBARD MED INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>G55598109</cusip>
    <value>417</value>
    <shrsOrPrnAmt>
      <sshPrnamt>443182</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>443182</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>LOXO ONCOLOGY INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>548862101</cusip>
    <value>105477</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4028920</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4028920</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>PERNIX THERAPEUTICS HLDGS IN</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>71426V108</cusip>
    <value>1246</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2010000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2010000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>T2 BIOSYSTEMS INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>89853L104</cusip>
    <value>20496</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2830992</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2830992</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>TRANSENTERIX INC.</nameOfIssuer>
    <titleOfClass>COM NEW</titleOfClass>
    <cusip>89366M201</cusip>
    <value>14088</value>
    <shrsOrPrnAmt>
      <sshPrnamt>8335819</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>8335819</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>VERSARTIS INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92529L102</cusip>
    <value>30925</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2524465</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2524465</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ZELTIQ AESTHETICS INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98933Q108</cusip>
    <value>63133</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1609727</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1609727</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>PARATEK PHARMACEUTICALS INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>699374302</cusip>
    <value>6280</value>
    <shrsOrPrnAmt>
      <sshPrnamt>482680</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>482680</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ADMA BIOLOGICS INC</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>000899104</cusip>
    <value>26159</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3608171</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3608171</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>AIMMUNE THERAPEUTICS INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00900T107</cusip>
    <value>44850</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2990000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2990000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CYNAPSUS THERAPEUTICS INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>23257Y859</cusip>
    <value>45102</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1121381</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1121381</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CIDARA THERAPEUTICS INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>171757107</cusip>
    <value>11692</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1021148</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1021148</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>PERNIX THERAPEUTICS HLDGS INC</nameOfIssuer>
    <titleOfClass>DEBT</titleOfClass>
    <cusip>71426VAK4</cusip>
    <value>675</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2500000</sshPrnamt>
      <sshPrnamtType>PRN</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2500000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>VIEWRAY INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92672L107</cusip>
    <value>33814</value>
    <shrsOrPrnAmt>
      <sshPrnamt>7480887</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>7480887</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>SYROS PHARMACEUTICALS, INC.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>87184Q107</cusip>
    <value>7054</value>
    <shrsOrPrnAmt>
      <sshPrnamt>508565</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>508565</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
</informationTable>
